Deans' stroke musings: Estimated stroke-free survival of folic acid therapy for hypertensive adults

Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Saturday, January 18, 2020

Estimated stroke-free survival of folic acid therapy for hypertensive adults

You'll have to ask your doctor to translate for your use.

Definition of hypertensive. Treated or untreated?

Protocols for treatment.

Prescription or over-the-counter?

Estimated stroke-free survival of folic acid therapy for hypertensive adults

Hypertension — Zhang T, Lin T, Wang Y, et al. | January 17, 2020

Researchers estimated the lifetime incremental stroke-free survival for enalapril-folic acid vs enalapril alone. They analyzed data from 19,053 participants and established adjusted models for competing risks and an age-based time scale. Findings revealed that a modest gain in lifetime stroke-free survival was achieved with enalapril plus folic acid treatment vs enalapril alone in hypertensive patients. In addition, certain subgroups were significantly benefited; greater gain in stroke-free survival was observed in younger, male patients, as well as those exhibiting lower baseline folate concentrations, higher baseline systolic blood pressure, higher baseline total cholesterol and blood glucose, and with MTHFR (methylenetetrahydrofolate reductase) C677T CT or TT genotype.